İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

KLARA DALVA

DOÇENT

ANKARA ÜNİVERSİTESİ KANSER ARAŞTIRMA ENSTİTÜSÜ TEMEL ONKOLOJİ ANABİLİM DALI

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Tıbbi Biyokimya

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 77
  • Proje 0
  • Kitap 0
  • Bildiri 68
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 17 Q2 19 Q3 14 Q4 10
WoS (JCR) Q1 12 Q2 10 Q3 16 Q4 21
TR Index 19 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 1
Üst %10 makale 3
Ort. yüzdelik 50.9%
Üst %1 payı 1.6%
Üst %10 payı 4.8%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 77 yayın

Scopus (SJR)
Q1 17 Q2 19 Q3 14 Q4 10
WoS (JCR)
Q1 12 Q2 10 Q3 16 Q4 21
TR Index
19 makale

Makale listesi

  1. 2025 Impact of PD-1 and PD-L1 expression on treatment outcomes in newly diagnosed acute myeloid leukemia patients Leukemia Research Reports DOI 10.1016/j.lrr.2025.100514 YÖKSİS SJR Q3 JCR Q4 OpenAlex üst %10 OpenAlex 91.1%
  2. 2025 Evaluation of Interleukin-10, Vascular Endothelial Growth Factor Levels, and Bone Marrow Parameters in Multiple Myeloma Patients at Diagnosis and After Treatment Diagnostics DOI 10.3390/diagnostics15131641 YÖKSİS SJR Q2 JCR Q1 OpenAlex 16.6%
  3. 2024 Determination of the Relationship Between the Development and Recurrence of Subacute Thyroiditis and Human Leukocyte Antigen Subtypes Genetic Testing and Molecular Biomarkers DOI 10.1089/gtmb.2023.0386 YÖKSİS SJR Q3 JCR Q4 OpenAlex 56.8%
  4. 2024 In vivo and in vitro effects of cord blood hematopoietic stem and progenitor cell (HSPC) expansion using valproic acid and/or nicotinamide Current Research in Translational Medicine DOI 10.1016/j.retram.2024.103444 YÖKSİS SJR Q2 JCR Q2 OpenAlex 64.7%
  5. 2024 Common human leucocyte antigens associated with the development of subacute thyroiditis and COVID-19 Human Immunology DOI 10.1016/j.humimm.2024.110834 YÖKSİS SJR Q2 JCR Q3 OpenAlex 67.0%
  6. 2023 A Novel Hypothesis: Certain KIR/Cognate Ligand Containing Genotypes Differ in Frequency Among Patients With Myeloma and Have an Effect on Age of Disease Onset Clinical Lymphoma Myeloma and Leukemia Elsevier BV DOI 10.1016/j.clml.2023.02.007 YÖKSİS SJR Q3 JCR Q2 OpenAlex 48.1%
  7. 2023 Role of large unstained cells in predicting successful stem cell collection in autologous stem cell transplantation Elsevier BV DOI 10.1016/j.transci.2022.103517 YÖKSİS SJR Q3 JCR Q4 OpenAlex 75.2%
  8. 2023 Two birds with one stone: a Bruton’s tyrosine kinase inhibitor in a patient with rheumatoid arthritis and 17p + chronic lymphocytic leukaemia Scandinavian Journal of Rheumatology DOI 10.1080/03009742.2023.2218206 YÖKSİS SJR Q2 JCR Q3 OpenAlex 48.8%
  9. 2022 Effect of CD34+ Total/Myeloid CD34+ Cell Progenitors and B-Lymphoid Progenitors Within the Bone Marrow Grafts on the Hematopoietic Recovery After Hematopoietic Stem Cell Transplantation Experimental and Clinical Transplantation DOI 10.6002/ect.2022.0210 YÖKSİS SJR Q3 JCR Q4 OpenAlex 22.5%
  10. 2022 Akut Lösemilerde Ölçülebilir Kalıntı Hastalığın Önemi Türkiye Klinikleri Hematoloji -Özel Konular YÖKSİS
  11. 2021 Pleural Involvement Upon Relapse of Myeloma Responding to Daratumumab Plus Carfilzomib: A Case Presentation and Literature Review Clinical Lymphoma Myeloma and Leukemia DOI 10.1016/j.clml.2020.11.017 YÖKSİS SJR Q2 JCR Q3 OpenAlex 48.9%
  12. 2021 A model integrating Killer Immunoglobulin-like Receptor (KIR) haplotypes for risk prediction of COVID-19 clinical disease severity Immunogenetics DOI 10.1007/s00251-021-01227-4 YÖKSİS SJR Q2 JCR Q3 OpenAlex 53.7%
  13. 2021 Single-Center Study of 72 Patients with Severe Combined Immunodeficiency: Clinical and Laboratory Features and Outcomes Journal of Clinical Immunology DOI 10.1007/s10875-021-01062-y YÖKSİS SJR Q1 JCR Q1 OpenAlex 64.4%
  14. 2021 Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN study British Journal of Haematology DOI 10.1111/bjh.17326 YÖKSİS SJR Q1 JCR Q1 OpenAlex 76.0%
  15. 2021 Leukemic stem cells shall be searched in the bone marrow before “tyrosine kinase inhibitor-discontinuation” in chronic myeloid leukemia International Journal of Laboratory Hematology DOI 10.1111/ijlh.13528 YÖKSİS SJR Q2 JCR Q3 OpenAlex 73.0%
  16. 2021 Significance of inhibitory maternal killer-cell immunoglobulin-like receptor (KIR) and fetal KIR ligand genotype combinations in placenta related obstetric complications Journal of Reproductive Immunology DOI 10.1016/j.jri.2021.103425 YÖKSİS SJR Q1 JCR Q2 OpenAlex 46.3%
  17. 2021 Highlighting the Prognostic Importance of Measurable Residual Disease Among Acute Myeloid Leukemia Risk Factors Turkish Journal of Hematology DOI 10.4274/tjh.galenos.2020.2020.0157 YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 0.9%
  18. 2021 Akut Myeloid Lösemi Tanısı ile Akraba Dışı Vericiden Allojeneik Hematopoietik Kök Hücre Nakli Yapılan Hastalarda ATG Kullanımının Nakil Sonuçlarına Etkisi Ankara Üniversitesi Tıp Fakültesi Mecmuası DOI 10.4274/atfm.galenos.2021.95866 YÖKSİS OpenAlex 13.0%
  19. 2021 The Influence of ATG on the Outcomes of Patients With AML at the Time of Unrelated Donor Transplantation Journal of Ankara University Faculty of Medicine DOI 10.4274/atfm.galenos.2021.95866 YÖKSİS TR Index OpenAlex 13.1%
  20. 2020 Long-Term Outcomes of Tamoxifen Citrate Therapy and Histo- and Immunopathological Properties in Riedel Thyroiditis European Thyroid Journal DOI 10.1159/000512017 YÖKSİS SJR Q1 JCR Q2 OpenAlex 64.1%

Akademisyenlere dön